CONMED Cost of Goods Sold 2010-2024 | CNMD

CONMED cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
CONMED Annual Cost of Goods Sold
(Millions of US $)
2023 $568
2022 $474
2021 $443
2020 $402
2019 $430
2018 $391
2017 $365
2016 $355
2015 $337
2014 $336
2013 $350
2012 $361
2011 $350
2010 $348
2009 $357
CONMED Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $138
2024-06-30 $148
2024-03-31 $140
2023-12-31 $145
2023-09-30 $137
2023-06-30 $147
2023-03-31 $140
2022-12-31 $119
2022-09-30 $123
2022-06-30 $125
2022-03-31 $106
2021-12-31 $118
2021-09-30 $107
2021-06-30 $114
2021-03-31 $104
2020-12-31 $117
2020-09-30 $104
2020-06-30 $86
2020-03-31 $95
2019-12-31 $123
2019-09-30 $103
2019-06-30 $107
2019-03-31 $97
2018-12-31 $110
2018-09-30 $92
2018-06-30 $97
2018-03-31 $93
2017-12-31 $99
2017-09-30 $88
2017-06-30 $93
2017-03-31 $87
2016-12-31 $97
2016-09-30 $84
2016-06-30 $91
2016-03-31 $83
2015-12-31 $89
2015-09-30 $76
2015-06-30 $88
2015-03-31 $86
2014-12-31 $91
2014-09-30 $79
2014-06-30 $87
2014-03-31 $79
2013-12-31 $92
2013-09-30 $84
2013-06-30 $90
2013-03-31 $84
2012-12-31 $94
2012-09-30 $84
2012-06-30 $90
2012-03-31 $93
2011-12-31 $89
2011-09-30 $82
2011-06-30 $92
2011-03-31 $88
2010-12-31 $93
2010-09-30 $83
2010-06-30 $87
2010-03-31 $85
2009-12-31 $95
2009-09-30 $88
2009-06-30 $87
2009-03-31 $88
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.312B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74